Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
9/30/2025 | $ 522.47M | $ 83.69M | 16.02% |
6/30/2025 | $ 591.55M | $ 88.38M | 14.94% |
3/31/2025 | $ 615.04M | $ 56.42M | 9.17% |
12/31/2024 | $ 669.34M | $ 54.55M | 8.15% |
9/30/2024 | $ 513.6M | $ 56.42M | 10.99% |
6/30/2024 | $ 511.03M | $ 62.3M | 12.19% |
3/31/2024 | $ 312.67M | $ 80.89M | 25.87% |
12/31/2023 | $ 355.6M | $ 76.99M | 21.65% |
9/30/2023 | $ 308.19M | $ 68.61M | 22.26% |
6/30/2023 | $ 350.62M | $ 60.94M | 17.38% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for NURIX THERAPEUTICS INC is calculated as follows: GP [ $ 17.82M ] / Assets [ $ 396.34M ]
(=) GPA [ 4.5% ]
Minimum
Jun 30, 2021
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.95% |